Introduction
It has been consistently reported that plasma angiotensin-converting enzyme (kininase II; E.C.
3.4.15.1; ACE) is elevated in patients with hyperthyroidism' 4, and correlations have been demonstrated between ACE and the free fractions of the plasma thyroid hormones5. There is, as yet, no explanation of this relationship although several hypotheses have been offered. It has been reported that, in patients with hyperthyroidism, liver function tests are abnormal6 7.
This may reflect a more general phenomenon in hyperthyroidism, wherein tissue damage occurs and the elevated ACE levels would be reflecting more widespread cell damage. Alternatively, Yotsumoto et al.' suggested that the elevation of plasma ACE in hyperthyroid patients might be due to an increase in circulating plasma proteases which could cleave ACE from the luminal surface of the lung endothelium. A third hypothesis is that thyroid hormones may have a direct effect upon synthesis or secretion ofACE. We have undertaken three pilot studies in an attempt to discriminate between these hypotheses.
Patients and methods
The first study was designed to investigate whether increased plasma ACE levels could be a consequence ofcell damage. Therefore, patients with four different classes of tissue damage, all of which were partly quantifiable by biochemical markers, were chosen: (a) 40 patients with myocardial infarction; (b) 40 with various liver diseases; (c) 40 with carcinoma of the prostate; and (d) 50 with varying degrees of renal failure. Plasma ACE levels were measured8 and correlated with (1) creatine kinase, aspartate transaminase and urea-stable lactate dehydrogenase;
(2) alanine aminotransferase, gammaglutamyltransferase and alkaline phosphatase; (3) prostatic acid phosphatase; and (4)urea and creatinine concentrations.
In the second study the effect of thyroid hormones upon tissue and plasma ACE levels in vivo was investigated. Any relative shift of ACE from, for example, the lung to the plasma would be consistent with Yotsumoto's hypothesis of release via circulating protease activity. Twenty-two male Sprague-Dawley rats were given thyroxine (T4), triiodothyronine (T3) or placebo for up to 3 weeks. At the end of the study plasma T4, T3 and ACE were measured. The animals were then sacrificed and various tissues removed, pooled and homogenized. The specific activities of 0141-0768/87/ 080484-02/$02.00/0 © 1987 The Royal Society of Medicine ACE (U/l/mg protein) in the cytosol and membrane fractions were calculated for each tissue. The third study was designed to investigate whether a direct effect of thyroid hormones upon cells could promote ACE synthesis or secretion as monitored by release ofACE into the growth medium of cultured cells. Endothelial cells were obtained from bovine aorta and grown in RPMI medium supplemented with 20% fetal calf serum and containing penicillin (50 iu/ml), streptomycin (50 ,pg/ml) and amphotericin B (2.5 ,ug/ml). Once confluent, the cells were subdivided into multiwell plates and varying concentrations of triiodothyronine were added. The medium was then sampled and ACE activity estimated at varying times from 0 to 72 h.
Results and discussion
Plasma ACE did not correlate with any of the indices oftissue damage in any ofthe four groups ofpatients. These data do not support the concept of a nonspecific release of ACE from damaged tissues. As ACE is a membrane-bound enzyme, this is perhaps a predictable result.
In the in vivo study with the rats, plasma T4 increased 4-fold in the T4-treated group and plasma T3 increased 60% in the T3-treated group; however, plasma ACE did not increase above reference ranges, nor was there a significant difference between the mean ACE levels in the three groups of rats. There was a marked increase in the specific activity of ACE in the lung cytosol fraction in the treated rats; 50-fold after T3, 4-fold after T4, by comparison with levels in the control group (Table 1) . Increases in circulating protease levels would be expected, initially, to cause a rise in plasma ACE with a concomitant drop in the specific activity of ACE in lung. Our data do not support such a hypothesis. The data are, however, consistent with thyroid hormones having a direct effect on ACE synthesis. The results from the cell culture study support the findings in the in vivo study. We were able to demonstrate a highly significant increase in ACE activity in the culture medium ofcells which had been incubated with triiodothyronine ( Table 2 ). These data indicate that 10-8M T3 is capable of directly inducing a marked increase in ACE secretion. The level of the increment in ACE output suggests that some ACE synthesis is likely to be involved, but further studies are required to confirm this.
